Clinical Trial Update: Phase II Study of Clinical Activity of Pegaspargase in Women With Relapsed or Refractory Epithelial Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer [Phase 2]

View source ↗

Summary

Phase II trial evaluating the activity of pegaspargase in women with relapsed or refractory epithelial ovarian cancer, fallopian tube cancer, and/or primary per…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Pegaspargase (pegaspargase)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Ovarian Neoplasms, Fallopian Tube Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2012-09-12